Movement Alert｜Boston Scientific Falls 3.05% in Regular Trading, Multiple Investment Banks Slash Target Prices

Market Focus06-25

On June 25, Boston Scientific fell 3.05% in regular trading, trading at $44.225/share, with turnover of $603 million. The stock continues to trade near its 52-week low amid intensifying analyst downgrades.

On the news front, Jefferies on June 24 slashed its target price on Boston Scientific from $100 to $67, a 33% reduction, while maintaining a buy rating. This follows Piper Sandler's earlier cut from $90 to $65, representing a 28% decrease. According to FactSet, the current average analyst target price stands at $74.67. The rapid succession of significant target price reductions has notably weighed on market sentiment, with the stock declining steadily over recent sessions.

Boston Scientific's next earnings report is scheduled for July 29 pre-market, and the market may be pricing in uncertainty ahead of the release.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1198838817?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-25 03:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1198838817","market":"us","top_or_hot":-1,"title":"Movement Alert｜Boston Scientific Falls 3.05% in Regular Trading, Multiple Investment Banks Slash Target Prices","media":"Market Focus","content":"<p><p>On June 25, Boston Scientific fell 3.05% in regular trading, trading at $44.225/share, with turnover of $603 million. The stock continues to trade near its 52-week low amid intensifying analyst downgrades.</p><p>On the news front, Jefferies on June 24 slashed its target price on Boston Scientific from $100 to $67, a 33% reduction, while maintaining a buy rating. This follows Piper Sandler's earlier cut from $90 to $65, representing a 28% decrease. According to FactSet, the current average analyst target price stands at $74.67. The rapid succession of significant target price reductions has notably weighed on market sentiment, with the stock declining steadily over recent sessions.</p><p>Boston Scientific's next earnings report is scheduled for July 29 pre-market, and the market may be pricing in uncertainty ahead of the release.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Boston Scientific Falls 3.05% in Regular Trading, Multiple Investment Banks Slash Target Prices</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Boston Scientific Falls 3.05% in Regular Trading, Multiple Investment Banks Slash Target Prices\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-25 03:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 25, Boston Scientific fell 3.05% in regular trading, trading at $44.225/share, with turnover of $603 million. The stock continues to trade near its 52-week low amid intensifying analyst downgrades.</p><p>On the news front, Jefferies on June 24 slashed its target price on Boston Scientific from $100 to $67, a 33% reduction, while maintaining a buy rating. This follows Piper Sandler's earlier cut from $90 to $65, representing a 28% decrease. According to FactSet, the current average analyst target price stands at $74.67. The rapid succession of significant target price reductions has notably weighed on market sentiment, with the stock declining steadily over recent sessions.</p><p>Boston Scientific's next earnings report is scheduled for July 29 pre-market, and the market may be pricing in uncertainty ahead of the release.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSX","symbol_name":"波士顿科学","start_time":0,"source_url":"","article_id":"1198838817","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1198838817","pubTimestamp":1782329986,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 25, Boston Scientific fell 3.05% in regular trading, trading at $44.225/share, with turnover of $603 million. The stock continues to trade near its 52-week low amid intensifying analyst...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSX":"波士顿科学"},"translate_title":"动向提示|波士顿科学常规交易跌3.05%多家投行大幅下调目标价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSX":1},"content_text":"On June 25, Boston Scientific fell 3.05% in regular trading, trading at $44.225/share, with turnover of $603 million. The stock continues to trade near its 52-week low amid intensifying analyst downgrades.On the news front, Jefferies on June 24 slashed its target price on Boston Scientific from $100 to $67, a 33% reduction, while maintaining a buy rating. This follows Piper Sandler's earlier cut from $90 to $65, representing a 28% decrease. According to FactSet, the current average analyst target price stands at $74.67. The rapid succession of significant target price reductions has notably weighed on market sentiment, with the stock declining steadily over recent sessions.Boston Scientific's next earnings report is scheduled for July 29 pre-market, and the market may be pricing in uncertainty ahead of the release.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1198838817","isCrawlerRequest":true}